IN Brief:
- UKBIC’s Flexible Pilot Line adds a lower-volume route between research-scale battery work and industrial scale-up in Coventry.
- The line is designed to cut material use and cost barriers for start-ups and SMEs validating new chemistries and processes.
- Early users include Echion and Ilika, highlighting demand for UK-based pilot manufacturing capacity across next-generation batteries.
UK Battery Industrialisation Centre has launched its Flexible Pilot Line in Coventry, adding a lower-volume scale-up route for British battery developers trying to move new chemistries and processes beyond laboratory work without jumping straight to full industrial production.
The new line is designed to reduce one of the biggest barriers facing smaller battery businesses: the amount of material and process risk needed to prove a technology at meaningful scale. Coventry City Council papers on UKBIC’s expansion describe the facility as offering 40-litre mixes, reducing material demand and lowering the cost of access for potential customers. Earlier UKBIC technical material also positioned the line as a bridge between small-scale R&D activity and the centre’s larger industrial scale-up capability.
That makes the FPL a practical addition to the UK’s battery manufacturing infrastructure rather than just another demonstration asset. It gives start-ups and SMEs a place to test process changes, validate manufacturability, and generate the performance evidence needed by investors, OEMs, and supply-chain partners before a move into higher-volume production.
UKBIC has already signalled the shape of demand. Echion was confirmed last year as the first company to use the line, while Ilika has also been identified as one of its early users as it advances solid-state battery development. That suggests the line will be used across a broad mix of emerging technologies rather than a single chemistry pathway.
For the wider power and electrification supply chain, the launch matters because the commercial bottleneck in batteries is often no longer the lab result but the manufacturable process. A pilot-scale line that is cheaper to access, smaller in batch size, and connected to a larger scale-up environment gives UK companies a better chance of keeping that learning, and the next investment round behind it, in the domestic market.
